@FierceBiotech: Superbug antibiotics: New drugs advance amid R&D investment shortfall. Special Report | Follow @FierceBiotech
> Xconomy caught up with Idera Pharmaceuticals ($IDRA) after the developer of drugs that target Toll-like receptors suffered a setback last week in its collaboration with German drug maker Merck KGaA. Idera, as the story notes, is still working with the other Merck ($MRK) and has money in the bank to continue its research. Article
> InSite Vision ($INSV), a developer of eye treatments, says that expects to receive gross proceeds of $22.2 million through a private placement of the firm's common stock and warrants. Release
> Array BioPharma ($ARRY) said has licensed a cancer drug called ARRY-543, which is entering Phase II trials, to Singapore-based ASLAN Pharmaceuticals. Item
> PharmaGap, an Ontario-based developer of peptide drugs, said it has competed the first close of a private financing for a total of $500,000. Announcement
> Montreal-based Thallion Pharmaceuticals ($TLN) said it has temporarily stopped the screening and enrollment of a high-dose cohort in a Phase II study of an antibody treatment in patients with STEC infections, as a precautionary measure after observing an "out-of-specification" finding in stability testing. Release
Pharma News
@FiercePharma: Novartis mulls IPO on China's planned int'l board. News | Follow @FiercePharma
> Studies: Gilead HIV drugs prevent transmission. Report
> Justice hits J&J with misdemeanor in Natrecor probe. Article
> Note to Pfizer: Bayer shopping for vet buys. Item
> Penn prof files complaint over ghostwritten Paxil study. News
> As rumors swirl, Shire eyes Vyvanse for binge eating. Article
> Hospitals want action on 'unprecedented' drug shortages. Report
Drug Delivery News
> Alnylam applies for trial of RNAi delivery tech for high cholesterol. Item
> MIT's Langer discusses targeted drug delivery. Report
> EnGeneIC, scientists search for antibodies to grab hold of tumors. Item
> Multitasking gel, polymer chain could deliver many drugs at once. Article
> Instant nano-delivery vehicle for brain cancer, just add water. Story
Medical Device News
> Kinetic Concepts to be bought for $4.98B. News
> Medtronic asks for $2.5M to expand Jacksonville ops. Article
> Shuren talks CDRH performance, staffing in Boston. News
> Representatives discuss Scottish device, diagnostic biz. Story